Author:
Patel Tulsi,Iglesias David A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference43 articles.
1. Bellesoeur A, Thomas-Schoemann A, Allard M, et al. Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: clinical consequences. Crit Rev Oncol Hematol. 2018;129:102–12.
2. Cohen A, Maraveyas A, Beyer-Westendorf J, et al. COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study. Thromb J. 2018;16:21 1–9.
3. Imberti D, Benedetti R. Primary prophylaxis of VTE in cancer outpatients. Thrombosis Research. 2016;140S1:S103–8.
4. Wun T, White R. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol. 2010;22:9–23.
5. Streiff M, Holmstrom B, Angelini D, et al. Cancer-associated venous thromboembolic disease. In: NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. 2019. https://www.nccn.org/professionals/physician_gls/pdf/vte.pdf. Accessed 10 June 2019.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献